Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Impact of Metformin therapy on miR-9, miR-223, and miR-132 and inflammasome-related gen expression in obese and non-obes PCOS patients: A comparative study with healthy controls

PLOS One(2025)10.1371/journal.pone.0335280Source: DataRank Database

Impact of Metformin therapy on miR-9, miR-223, and miR-132 and inflammasome-related gen expression in obese and non-obes PCOS patients: A comparative study with healthy controls is a research paper published in PLOS One (2025). On theSindex it has a DataRank of 0.165. It has been cited 2 times.

N/A

0.165DataRank · unranked

Scored on demand from live citation data

2 citations

Download PDF

Cite:

Linked data & code

refseq

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.59)OA: goldTopics (26)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.165

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (8)

Seyed Mehdi Kalantar,Fateme Montazeri ORCID,Reyhaneh Azizi,Elham Hosseini ORCID,Fateme Zare

Live enrichment

PubMed:41411269 PMC:PMC12714236 OpenAlex:https://openalex.org/W4417473451

Shahrekord University of Medical Sciences

Grant: 6043

FWCI

0.59

Citation Percentile

0.8%

Citation Trend

2026

goldLicense: cc-by

journalhttps://doi.org/10.1371/journal.pone.0335280

publisherhttps://doi.org/10.1371/journal.pone.0335280

publisherhttps://dx.plos.org/10.1371/journal.pone.0335280

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41411269

repositoryhttps://doaj.org/article/035443a4f081403d80c0af7addc8eb7c

Fields of Study

MicroRNA in disease regulationAdipokines, Inflammation, and Metabolic DiseasesCardiovascular Function and Risk Factors

MeSH Terms

NLR Family, Pyrin Domain-Containing 3 ProteinAdolescentAdultFemaleGene Expression RegulationHumansHypoglycemic AgentsMetforminObesityPolycystic Ovary SyndromeCase-Control StudiesInterleukin-18MicroRNAsInterleukin-1betaYoung AdultInflammasomes

Keywords

MetforminInflammationmicroRNAGene expressionObesityInflammatory responseDiabetes mellitus

Impact of Metformin therapy on miR-9, miR-223, and miR-132 and inflammasome-related gen expression in obese and non-obes PCOS patients: A comparative study with healthy controls

FAIR Checklist

DataRank Breakdown

Authors (8)

Funding (1 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)